Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients Journal Article
| Authors: | McKenney, A. S.; Weg, E.; Bale, T. A.; Wild, A. T.; Um, H.; Fox, M. J.; Lin, A.; Yang, J. T.; Yao, P.; Birger, M. L.; Tixier, F.; Sellitti, M.; Moss, N. S.; Young, R. J.; Veeraraghavan, H. |
| Article Title: | Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients |
| Abstract: | Purpose: Pseudoprogression mimicking recurrent glioblastoma remains a diagnostic challenge that may adversely confound or delay appropriate treatment or clinical trial enrollment. We sought to build a radiomic classifier to predict pseudoprogression in patients with primary isocitrate dehydrogenase wild type glioblastoma. Methods and Materials: We retrospectively examined a training cohort of 74 patients with isocitrate dehydrogenase wild type glioblastomas with brain magnetic resonance imaging including dynamic contrast enhanced T1 perfusion before resection of an enhancing lesion indeterminate for recurrent tumor or pseudoprogression. A recursive feature elimination random forest classifier was built using nested cross-validation without and with O6-methylguanine–DNA methyltransferase status to predict pseudoprogression. Results: A classifier constructed with cross-validation on the training cohort achieved an area under the receiver operating curve of 81% for predicting pseudoprogression. This was further improved to 89% with the addition of O6-methylguanine–DNA methyltransferase status into the classifier. Conclusions: Our results suggest that radiomic analysis of contrast T1-weighted images and magnetic resonance imaging perfusion images can assist the prompt diagnosis of pseudoprogression. Validation on external and independent data sets is necessary to verify these advanced analyses, which can be performed on routinely acquired clinical images and may help inform clinical treatment decisions. © 2022 The Authors |
| Journal Title: | Advances in Radiation Oncology |
| Volume: | 8 |
| Issue: | 1 |
| ISSN: | 2452-1094 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-01-01 |
| Start Page: | 100916 |
| Language: | English |
| DOI: | 10.1016/j.adro.2022.100916 |
| PROVIDER: | scopus |
| PMCID: | PMC9873493 |
| PUBMED: | 36711062 |
| DOI/URL: | |
| Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- MSK corresponding author is Robert Young -- Export Date: 1 February 2023 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work